Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Eichenbaum

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Ophthalmology|May 21, 2021
Association of Early Anatomic Response with Visual Function in Neovascular Age-Related Macular DegenerationMichael Singer, Rishi P Singh, Andrea Gibson, et al.
The British Journal of Ophthalmology|May 29, 2020
Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN studySam E Mansour, Daniel F Kiernan, Daniel B Roth, et al.
Eye (London, England)|March 2, 2026
Aflibercept 2 mg Biosimilar (aflibercept-ayyh, Pavblu): Experience of safety in clinical settings-APEX- safety studyAshish Sharma, Arshad M Khanani, David Eichenbaum, et al.
American Journal of Ophthalmology|September 12, 2021
Inhibition of Complement Factor 3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study ResultsCharles C Wykoff, Vrinda Hershberger, David Eichenbaum, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|September 10, 2024
Development of a Consensus Guideline for the Diagnosis and Management of Chronic Noninfectious Uveitis Affecting the Posterior SegmentRishi P Singh, Thomas A Albini, Caroline R Baumal, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|January 8, 2024
Ocular, Visual, and Anatomical Outcomes in Eyes Requiring Incisional Intraocular Pressure-Lowering Surgery Following the 0.19-mg Fluocinolone Acetonide Intravitreal ImplantDavid Eichenbaum, Victor H Gonzalez, Daniel Roth, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 11, 2024
RWC Update: Removal of Subretinal Band Without Retinotomy; Geographic Atrophy: How Do You Select Appropriate Patients for Anti-Complement Therapy?; Shaken Baby SyndromeAshish Sharma, Lihteh Wu, Steven Bloom, et al.
Eye (London, England)|March 25, 2023
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trialSunil S Patel, David R Lally, Jason Hsu, et al.
Eye (London, England)|May 26, 2023
Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trialSunil S Patel, David R Lally, Jason Hsu, et al.
Retina (Philadelphia, Pa.)|January 27, 2023
IMPACT OF RETINAL FLUID-FREE MONTHS ON OUTCOMES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Treatment Agnostic Analysis of the HAWK and HARRIER StudiesDavid Eichenbaum, David M Brown, Michael Ip, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Ophthalmology|May 21, 2021
Association of Early Anatomic Response with Visual Function in Neovascular Age-Related Macular DegenerationMichael Singer, Rishi P Singh, Andrea Gibson, et al.
The British Journal of Ophthalmology|May 29, 2020
Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN studySam E Mansour, Daniel F Kiernan, Daniel B Roth, et al.
Eye (London, England)|March 2, 2026
Aflibercept 2 mg Biosimilar (aflibercept-ayyh, Pavblu): Experience of safety in clinical settings-APEX- safety studyAshish Sharma, Arshad M Khanani, David Eichenbaum, et al.
American Journal of Ophthalmology|September 12, 2021
Inhibition of Complement Factor 3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study ResultsCharles C Wykoff, Vrinda Hershberger, David Eichenbaum, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|September 10, 2024
Development of a Consensus Guideline for the Diagnosis and Management of Chronic Noninfectious Uveitis Affecting the Posterior SegmentRishi P Singh, Thomas A Albini, Caroline R Baumal, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|January 8, 2024
Ocular, Visual, and Anatomical Outcomes in Eyes Requiring Incisional Intraocular Pressure-Lowering Surgery Following the 0.19-mg Fluocinolone Acetonide Intravitreal ImplantDavid Eichenbaum, Victor H Gonzalez, Daniel Roth, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 11, 2024
RWC Update: Removal of Subretinal Band Without Retinotomy; Geographic Atrophy: How Do You Select Appropriate Patients for Anti-Complement Therapy?; Shaken Baby SyndromeAshish Sharma, Lihteh Wu, Steven Bloom, et al.
Eye (London, England)|March 25, 2023
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trialSunil S Patel, David R Lally, Jason Hsu, et al.
Eye (London, England)|May 26, 2023
Correction: Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trialSunil S Patel, David R Lally, Jason Hsu, et al.
Retina (Philadelphia, Pa.)|January 27, 2023
IMPACT OF RETINAL FLUID-FREE MONTHS ON OUTCOMES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Treatment Agnostic Analysis of the HAWK and HARRIER StudiesDavid Eichenbaum, David M Brown, Michael Ip, et al.
Pageof 3